A prospective study on the dynamics of the clinical and immunological evolution of human Leishmania (L.) infantum chagasi infection in the Brazilian Amazon region

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 104, Issue 8, 2010, Pages 529-535

  Silveira, Fernando T ^a,b   Lainson, Ralph ^a   Crescente, José Ângelo ^b   de Souza, Adelson A A ^a   Campos, Marliane B ^a   Gomes, Claudia M C ^c   Laurenti, Márcia D ^c   Corbett, Carlos E P ^c  

^a MINISTÉRIO DA SAÚDE   (Brazil)

^b Brazil Federal University Pará   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Brazil; Clinical examination; Dynamics evolution; Immunologic tests; Infection; Leishmania infantum chagasi

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BRAZIL; CELLULAR IMMUNITY; CHILD; CONTROLLED STUDY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; HUMORAL IMMUNITY; LEISHMANIA; LEISHMANIA INFANTUM CHAGASI; LEISHMANIN SKIN TEST; MAJOR CLINICAL STUDY; MALE; MOLECULAR EVOLUTION; VISCERAL LEISHMANIASIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIBODIES, PROTOZOAN; BRAZIL; CHILD; CHILD, PRESCHOOL; DOGS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; INFANT; LEISHMANIA INFANTUM; LEISHMANIASIS, VISCERAL; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; SKIN TESTS; YOUNG ADULT;

LEISHMANIA INFANTUM;

EID: 77954535277     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2010.05.002     Document Type: Article

References (28)

1. Holaday B.J., Pompeu M.M., Evans T., Braga D.N., Texeira M.J., Sousa A.Q., et al. Correlates of Leishmania-specific immunity in the clinical spectrum of infection with Leishmania chagasi. J. Infect. Dis. 1993, 167:411-417.
2. Vinhas V., Freire M., Bacellar O., Cunha S., Rocha H., Carvalho E.M. Characterization of T cell responses to purified Leishmania antigens in subjects infected with Leishmania chagasi. Braz. J. Med. Biol. Res. 1994, 27:1199-1205.
3. Costa S.R., D'Oliveira A., Bacellar O., Carvalho E.M. T cell response of asymptomatic Leishmania chagasi infected subjects to recombinant Leishmania antigens. Mem. Inst. Oswaldo Cruz 1999, 94:367-370.
4. Pearson R.D., Souza A.Q. Clinical spectrum of leishmaniasis. Clin. Infect. Dis. 1996, 22:1-13.
5. Badaró R., Jones T.C., Lorenço R., Cerf B.J., Sampaio D., Carvalho E.M., et al. A prospective study of visceral leishmaniasis in an endemic area of Brazil. J. Infect. Dis. 1986, 154:639-649.
6. Gama M.E.A., Costa J.M.L., Gomes C.M.C., Corbett C.E.P. Subclinical form of the American visceral leishmaniasis. Mem. Inst. Oswaldo Cruz 2004, 99:889-893.
7. Jerônimo S.M.B., Teixeira M.V., Sousa A.Q., Thielking P., Pearson R.D., Evans T.G. Natural history of Leishmania (Leishmania) chagasi infection in Northeastern Brazil: long-term follow-up. Clin. Infect. Dis. 2000, 30:608-609.
8. Crescente J.A.B., Silveira F.T., Lainson R., Gomes C.M.C., Laurenti M.D., Corbett C.E.P. A cross-sectional study on the clinical and immunological spectrum of human Leishmania (L.) infantum chagasi infection in the Brazilian Amazon region. Trans. R. Soc. Trop. Med. Hyg. 2009, 103:1250-1256.
9. Jerônimo S.M.B., Holst A.K., Jamieson S.E., Francis R., Martins D.R., Bezerra F.L., et al. Genes at human chromosome 5q31.1 regulate delayed-type hypersensitivity responses associated with Leishmania chagasi infection. Genes Immun. 2007, 8:539-551.
10. Zijlstra E.E., El-Hassan A.M., Ismael A., Ghalib H.W. Endemic kala-azar in eastern Sudan: a longitudinal study on the incidence of clinical and subclinical infection and post-kala-azar dermal leishmaniasis. Am. J. Trop. Med. Hyg. 1994, 51:826-836.
11. Brasil Ministério da Saúde, 2003. Manual de vigilância e controle da leishmaniose visceral. Brasília-DF, Ministério da Saúde, Secretaria de Vigilância em Saúde, Departamento de Vigilância Epidemiológica.
12. Lima L.V.R., de Souza A.A.A., Jennings Y.L., Corrêa Z., de Jesus R., Everdosa D., et al. Comparison of the reactivity between antigens of Leishmania (L.) chagasi, L. (L.) amazonensis and Leishmania sp. (Bio-Manguinhos) in the sero-diagnosis of visceral leishmaniasis by the indirect fluorescent antibody test (IFAT). Rev. Inst. Med. Trop. São Paulo 2003, 45(Suppl 13):147.
13. Silveira F.T., Lainson R., Shaw J.J., de Souza A.A., Ishikawa E.I.A., Braga R.R. Cutaneous leishmaniasis due to Leishmania (Leishmania) amazonensis in Amazonian Brazil, and the significance of a negative Montenegro skin test in human infections. Trans. R. Soc. Trop. Med. Hyg. 1991, 85:735-738.
14. Ayres M., Ayres M., Ayres D., dos Santos A.S. Bioestat 4.0: aplicações estatísticas nas áreas das ciências biológicas e médicas 2004, Sociedade Civil Mamirauá-Brasília CNPq, Belém, PA.
15. Ali A., Ashford R.W. Visceral leishmaniasis in Ethiopia. II. Annual leishmanin transformation in a population. Is positive leishmanin reaction a life-long phenomenon?. Ann. Trop. Med. Parasitol. 1993, 87:163-167.
16. Davies C.R., Mazloumi Gavgani A.S. Age, acquired immunity and the risk of visceral leishmaniasis: a prospective study in Iran. Parasitology 1999, 119:247-257.
17. Silveira F.T., Lainson R., de Souza A.A.A., Ishikawa E.A.I., Laurent M.D., Corbett C.E.P. Failure of natural immunity induced by asymptomatic Leishmania chagasi infection in protecting against Leishmania braziliensis cutaneous disease. Third World Congress on Leishmaniasis 2005, 278.
18. Caldas A.J.M., Costa J.M.L., Silva A.A.M., Vinhas V., Barral A. Risk factors associated with infection by Leishmania chagasi in north-east Brazil. Trans. R. Soc. Trop. Med. Hyg. 2002, 96:21-28.
19. Nascimento M.D.S.B., Souza E.C., da Silva L.M., da Cunha Leal P., de Lima Cantanhede K., de Barros Bezerra G.F., et al. Prevalência de infecção por Leishmania chagasi utilizando os métodos de ELISA (rK39 e CRUDE) e intradermorreação de Montenegro em área endêmica do Maranhão, Brasil. Cad. Saúde Pública 2005, 21:1801-1807.
20. Pampiglione S., Manson-Bahr P.E.C., La Placa M., Borgatti M.A., Musumeci S. Studies in Mediterranean leishmaniasis: 3. The leishmanin skin test in kala-azar. Trans. R. Soc. Trop. Med. Hyg. 1975, 69:60-68.
21. Badaró R., Jones T.C., Carvalho E.M., Sampaio D., Reed S.G., Barral A., et al. New perspectives on a subclinical form of visceral leishmaniasis. J. Infect. Dis. 1986, 154:1003-1012.
22. Ali A., Ashford R.W. Visceral leishmaniasis in Ethiopia. I. Cross-sectional leishmanin skin test in an endemic locality. Ann. Trop. Med. Parasitol. 1993, 87:157-161.
23. Blackwell J.M., Mohamed H.S., Ibrahim M.E. Genetics and visceral leishmaniasis in the Sudan: seeking a link. Trends Parasitol. 2004, 6:268-274.
24. Jamieson S.E., Miller E.M., Peacock C.S., Fakiola M., Wilson M.E., Bales-Holst A., et al. Geome-wide scan for visceral leishmaniasis susceptibility genes in Brazil. Genes Immun. 2007, 8:84-90.
25. Malla N., Mhajan R.C. Pathophysiology of visceral leishmaniasis-some recent concepts. Indian J. Med. Res. 2006, 123:267-274.
26. Bacellar O., Barral-Neto M., Badaró R., Carvalho E.M. Gamma interferon production by lymphocytes from children infected with L. chagasi. Braz. J. Med. Biol. Res. 1991, 24:791-795.
27. De Luca P.M., Mayrink W., Santiago M.A., Nogueira R., Conceição-Silva F., Melo G., et al. Randomized, double-blind, placebo-controlled study on the immunogenicity of the leishmanin skin test. Trans. R. Soc. Trop. Med. Hyg. 2003, 97:709-712.
28. Bacellar O., D'Oliveira A., Jerônimo S., Carvalho E.M. IL-10 and IL-12 are the main regulatory cytokines in visceral leishmaniasis. Cytokine 2000, 12:1228-1231.